Oculis AG(OCS) - 2025 FY - Earnings Call Transcript

Oculis Holding AG (OCS) FY 2025 Conference May 20, 2025 09:30 AM ET Speaker0 For this session, we'll have a presentation by Oculus. Oculus is a clinical stage ophthalmology company with a pipeline of candidates targeting diabetic macular edema, dry eye disease and acute optic neuritis. Presenting for the company is Ms. Silva Chin, Chief Financial Officer of Oculus. Speaker1 Thank you. Good morning, everyone. Thank you for your patience, and thank you, Yi, for the introduction. Thanks to H. C. Ringwright for ...